Nutritional composition for infants
    3.
    发明授权
    Nutritional composition for infants 有权
    婴幼儿营养成分

    公开(公告)号:US08999926B2

    公开(公告)日:2015-04-07

    申请号:US13787170

    申请日:2013-03-06

    申请人: Nestec S.A.

    摘要: A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % α-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid:α-linolenic acid is in the range from 1 to 10.

    摘要翻译: 用于婴儿的营养组合物包含蛋白质来源,脂质来源和碳水化合物源,其中所述脂质源包含至少16重量%的亚油酸和至少2重量%的α-亚麻酸,以每个中的总脂肪酸含量的百分数表示 情况,其量使得亚油酸:α-亚麻酸的比例在1至10的范围内。

    NUTRITIONAL COMPOSITION FOR INFANTS
    4.
    发明申请
    NUTRITIONAL COMPOSITION FOR INFANTS 有权
    营养组合物用于婴儿

    公开(公告)号:US20130177667A1

    公开(公告)日:2013-07-11

    申请号:US13787170

    申请日:2013-03-06

    申请人: NESTEC S.A.

    IPC分类号: A23L1/29

    摘要: A nutritional composition for infants comprises a protein source, a lipid source and a carbohydrate source wherein the lipid source includes at least 16 wt % linoleic acid and at least 2 wt % α-linolenic acid expressed as a percentage of total fatty acid content in each case and in amounts such that the ratio of linoleic acid: α-linolenic acid is in the range from 1 to 10.

    摘要翻译: 用于婴儿的营养组合物包含蛋白质来源,脂质源和碳水化合物源,其中所述脂质源包含至少16重量%的亚油酸和至少2重量%的α-亚麻酸,以每个中的总脂肪酸含量的百分比表示 情况,其用量使得亚油酸:α-亚麻酸的比例在1至10的范围内。

    USE OF WHEY PROTEIN MICELLES FOR IMPROVING INSULIN PROFILE IN DIABETIC PATIENTS
    6.
    发明申请
    USE OF WHEY PROTEIN MICELLES FOR IMPROVING INSULIN PROFILE IN DIABETIC PATIENTS 审中-公开
    用于改善糖尿病患者胰岛素特征的WHEY蛋白质细胞的使用

    公开(公告)号:US20140255544A1

    公开(公告)日:2014-09-11

    申请号:US14353188

    申请日:2012-10-19

    申请人: NESTEC S.A.

    IPC分类号: A23J1/20 A23L1/29

    摘要: The present invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in plasma postprandial insulin and/or plasma postprandial glucagon concentration in a subject. The invention relates also to a non-therapeutic use of whey protein micelles to decrease plasma postprandial insulin and/or glucagon concentration in healthy subjects.

    摘要翻译: 本发明涉及用于治疗和/或预防与受试者中血浆餐后胰岛素和/或血浆餐后胰高血糖素浓度增加相关的障碍的乳清蛋白胶束。 本发明还涉及乳清蛋白胶束在健康受试者中降低血浆餐后胰岛素和/或胰高血糖素浓度的非治疗用途。

    USE OF WHEY PROTEIN MICELLES FOR INFANTS AT RISK OF OBESITY OR DIABETES
    10.
    发明申请
    USE OF WHEY PROTEIN MICELLES FOR INFANTS AT RISK OF OBESITY OR DIABETES 审中-公开
    用于患有肥胖或糖尿病风险的婴儿的WHEY蛋白质细胞

    公开(公告)号:US20140287056A1

    公开(公告)日:2014-09-25

    申请号:US14353206

    申请日:2012-10-19

    申请人: NESTEC S.A.

    IPC分类号: A61K35/20 A23L1/29 A61K38/01

    摘要: The invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in insulin secretion and/or plasma IGF-1 concentration in an infant at risk of developing obesity or diabetes. The invention also relates to a nutritional composition for infants comprising whey protein micelles. Further, the invention relates to a non-therapeutic use of a nutritional composition for infants, comprising whey protein micelles.

    摘要翻译: 本发明涉及用于治疗和/或预防与发展为肥胖或糖尿病风险的婴儿中胰岛素分泌增加和/或血浆IGF-1浓度相关的病症的乳清蛋白胶束。 本发明还涉及包含乳清蛋白胶束的婴儿的营养组合物。 此外,本发明涉及用于婴儿的营养组合物的非治疗用途,其包含乳清蛋白胶束。